(Q24538637)

6 July 2017

title

Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa (English)

1 reference

6 July 2017

1 reference

1 reference

1 reference

J Dingemanse

1

1 reference

6 July 2017

K Jorga

2

1 reference

6 July 2017

G Zürcher

3

1 reference

6 July 2017

M Schmitt

4

1 reference

6 July 2017

G Sedek

5

1 reference

6 July 2017

M Da Prada

6

1 reference

6 July 2017

P Van Brummelen

7

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 September 1995

1 reference

British Journal of Clinical Pharmacology

6 July 2017

published in

1 reference

6 July 2017

volume

40

1 reference

6 July 2017

issue

3

1 reference

6 July 2017

page(s)

253-262

1 reference

The pharmacology of Parkinson's disease: basic aspects and recent advances

6 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

On-off phenomenon: relation to levodopa pharmacokinetics and pharmacodynamics

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

Clinical pharmacokinetics of anti-parkinsonian drugs

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

Neuropharmacology of S-adenosyl methionine

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

Current drug therapy for Parkinson's disease. A review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

Depression and Parkinson's disease: a review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

Catechol-O-methyl transferase: pharmacological aspects and physiological role

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

The metabolism of L-3-0-methyldopa, aprecursor of dopa in man

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1365105

Clinical Potential of Catechol-OMethyltransferase (COMT) Inhibitors as Adjuvants in Parkinson's Disease

30 May 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1995.TB05781.X

Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1995.TB05781.X

The influence of levodopa on gastric emptying in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1995.TB05781.X

L-3,4-dihydroxyphenylalanine (levodopa) lowers central nervous system S-adenosylmethionine concentrations in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1995.TB05781.X

Pharmacokinetics of Levodopa

21 January 2018

1 reference

12 December 2020

Human erythrocyte catechol-o-methyltransferase: Correlation with lung and kidney activity

1 reference

12 December 2020

Catechol-O-methyltransferase activity in human and rat small intestine

1 reference

12 December 2020

Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-dopa in healthy volunteers

1 reference

12 December 2020

Simple automated high-performance liquid chromatographic column-switching technique for the measurement of dopa and 3-O-methyldopa in plasma

1 reference

12 December 2020

Determination of the catechol-O-methyltransferase inhibitor Ro 40-7592 in human plasma by high-performance liquid chromatography with coulometric detection

1 reference

12 December 2020

The effect of exercise on levodopa absorption

1 reference

12 December 2020

The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers

1 reference

12 December 2020

Ro 40-7592, a COMT inhibitor, plus levodopa in Parkinson's disease

1 reference

12 December 2020

Treatment of Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

Assay for catechol-O-methyltransferase in erythrocytes using a new fluorogenic substrate, 2-(3,4-dihydroxyphenyl)naphtho[1,2-d]thiazole

1 reference

12 December 2020

10.1111/J.1365-2125.1995.TB05781.X

Identifiers

DOI

1 reference

6 July 2017

1 reference

6 July 2017

1 reference